Aleta Biotherapeutics news: Come hear our talk on a novel therapeutic to counter relapses in ALL & NHL patients treated with CD19 CAR-T cells. Half of these patients relapse in under a year, our goal is to rescue them.
#ASH19aletabio.combusinesswire.com/news/home/2…